The MRC/BHF Heart Protection Study: preliminary results.
Collins R. et al, (2002), Int J Clin Pract, 56, 53 - 56
[Statin treatment of cardiac risk patients means: 1. Far more patients benefit, 2. Initial LDL doesn't matter].
Einecke D., (2001), MMW Fortschr Med, 143, 12 - 14
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack.
PROGRESS Collaborative Group None., (2001), Lancet, 358, 1033 - 1041
A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. men.
Ridker PM. et al, (2001), Ann Intern Med, 135, 184 - 188
Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol.
Sever PS. et al, (2001), J Hum Hypertens, 15 Suppl 1, S11 - S12
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators.
Sever PS. et al, (2001), J Hypertens, 19, 1139 - 1147
Benefit of aspirin plus angiotensin-converting enzyme inhibitor.
Baigent C. et al, (2001), J Am Coll Cardiol, 37, 1474 - 1475
Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies.
MacMahon S. and Collins R., (2001), Lancet, 357, 455 - 462
Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials.
Collins R. and MacMahon S., (2001), Lancet, 357, 373 - 380
Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
Second Chinese Cardiac Study (CCS-2) Collaborative Group None., (2000), J Cardiovasc Risk, 7, 435 - 441
Immediate versus deferred zidovudine (AZT) in asymptomatic or mildly symptomatic HIV infected adults
Darbyshire J. et al, (2000), Praxis, 89
Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults
Darbyshire J. et al, (2000), Praxis, 89
Large-scale test of hypothesised associations between polymorphisms of lipid-related genes and myocardial infarction in about 5000 cases and 6000 controls
Keavney BD. et al, (2000), CIRCULATION, 102, 852 - 852
Plasma fibrinogen and fibrinogen genotypes in 4685 cases of myocardial infarction and in 6002 controls: Test of causality by "Mendelian randomisation"
Youngman LD. et al, (2000), CIRCULATION, 102, 31 - 32
Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials.
Armitage J. and Collins R., (2000), Heart, 84, 357 - 360
Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies.
Danesh J. et al, (2000), Circulation, 102, 1082 - 1085
Re-survey of the Whitehall study of London civil servants: changes in risk factors for cardiovascular disease during 29 years of follow-up.
Clarke R. et al, (2000), J Cardiovasc Risk, 7, 251 - 257
Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-converting Enzyme Inhibitor Myocardial Infarction Collaborative Group.
Latini R. et al, (2000), J Am Coll Cardiol, 35, 1801 - 1807